Arteris(AIP) - 2025 Q1 - Quarterly Results

Financial Performance - Revenue for Q1 2025 was $16.5 million, representing a 28$66.8 million, up 15% year-over-year, marking the highest level reported[5] - Remaining performance obligation (RPO) was $88.9 million, a 19$2.7 million, equating to 16% of revenue[5] - Non-GAAP gross profit increased to $15,261 million for the three months ended March 31, 2025, compared to$11,718 million in 2024, reflecting a growth of approximately 30.4%[32] - Non-GAAP gross margin improved to 92% for the three months ended March 31, 2025, up from 91% in the same period of 2024[32] - Free cash flow for the three months ended March 31, 2025, was $2,677 million, significantly higher than$281 million in 2024, marking an increase of over 850%[35] - Non-GAAP net loss for the three months ended March 31, 2025, was $3,591 million, compared to$5,554 million in 2024, indicating a decrease of approximately 35.4%[32] - Net loss for the three months ended March 31, 2025, was $8,121 million, an improvement from a net loss of$9,403 million for the same period in 2024, indicating a reduction of about 13.6%[21] Guidance and Projections - Estimated Q2 2025 revenue guidance is between $16.1 million and$16.5 million[7] - Full year 2025 revenue guidance is projected between $65.0 million and$71.0 million[7] - Non-GAAP operating loss for Q2 2025 is estimated to be between $3.0 million and$4.0 million[7] Customer and Partnership Developments - The company added another top global automotive OEM to its customer list, now having direct license agreements with 10 automotive OEMs[5] - Arteris joined the Intel Foundry Accelerator program, enhancing its network of ecosystem partners[5] - The company opened a new engineering and customer support center in Krakow, Poland, to support development efforts[11] Asset and Liability Management - Total assets decreased from $106,135 million as of December 31, 2024, to$98,319 million as of March 31, 2025, representing a decline of approximately 7.5%[19] - Total current liabilities decreased from $59,282 million as of December 31, 2024, to$56,539 million as of March 31, 2025, a reduction of approximately 4.6%[19] - Total liabilities decreased from $107,323 million as of December 31, 2024, to$103,140 million as of March 31, 2025, a decline of about 3.6%[19] Research and Development - Research and development expenses rose to $11,862 million for the three months ended March 31, 2025, compared to$10,835 million in 2024, an increase of about 9.5%[32] Shareholder Information - The number of weighted average shares used in computing per share amounts increased from 37,709,058 in 2024 to 40,853,048 in 2025, reflecting a growth of approximately 8.5%[34]